Werewolf Therapeutics (HOWL) Total Liabilities (2020 - 2026)

Werewolf Therapeutics (HOWL) has reported Total Liabilities for 7 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities fell 84.61% year-over-year to $7.9 million in Q2 2026; TTM through Jun 2026 was $7.9 million, a 84.61% decrease from a year earlier, with the FY2025 full-year figure at $44.6 million, down 16.71% from the prior year.
• Total Liabilities was $7.9 million for Q2 2026 at Werewolf Therapeutics, down from $45.8 million in the prior quarter.
• Over five years, Total Liabilities peaked at $74.0 million in Q1 2023 and troughed at $7.9 million in Q2 2026.
• A 5-year average of $49.0 million and a median of $50.0 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 413.29% in 2022 and sank 84.61% in 2026, its largest moves.
• Over 5 years, Total Liabilities stood at $37.9 million in 2022, then soared by 67.4% to $63.5 million in 2023, then retreated by 15.63% to $53.5 million in 2024, then declined by 16.71% to $44.6 million in 2025, then sank by 82.37% to $7.9 million in 2026.
• The last three Total Liabilities figures came in at $7.9 million (Q2 2026), $45.8 million (Q1 2026), and $44.6 million (Q4 2025), per Business Quant data.